We are live on
!
Find out more
State Street SPDR S&P Biotech ETF
779 hedge funds and large institutions have $9.75B invested in State Street SPDR S&P Biotech ETF in 2024 Q1 according to their latest regulatory filings, with 129 funds opening new positions, 257 increasing their positions, 233 reducing their positions, and 83 closing their positions.
New
Increased
Maintained
Reduced
Closed
55% more first-time investments, than exits
New positions opened: 129 | Existing positions closed: 83
22% more capital invested
Capital invested by funds: $8.02B → $9.75B (+$1.73B)
20.35% more ownership
Funds ownership: 110.47% → 130.81% (+20%)
10% more repeat investments, than reductions
Existing positions increased: 257 | Existing positions reduced: 233
5% more funds holding
Funds holding: 744 → 779 (+35)
0% more funds holding in top 10
Funds holding in top 10: 23 → 23 (0)
43% less call options, than puts
Call options by funds: $2.25B | Put options by funds: $3.97B
Holders
779
Holders Change
+35
Holders Change %
+4.7%
% of All Funds
11.22%
Holding in Top 10
23
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.33%
New
129
Increased
257
Reduced
233
Closed
83
Calls
$2.25B
Puts
$3.97B
Net Calls
-$1.72B
Net Calls Change
-$470M
Top Buyers
| 1 |
Citigroup
New York
|
+$437M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$382M |
| 3 |
JP Morgan Chase
New York
|
+$348M |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$274M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$128M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$318M |
| 2 |
MCM
Moore Capital Management
New York
|
-$146M |
| 3 |
Twin Tree Management
Dallas,
Texas
|
-$65.3M |
| 4 |
Millennium Management
New York
|
-$64.2M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$56.6M |
